Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A5 (FAM90A5) is a member of the primate-specific FAM90A gene family, thought to arise from multiple gene duplications and rearrangements[1]. The gene is commonly annotated as a **pseudogene** (sometimes referred to as "FAM90A5P") and there is no evidence that it encodes a functional protein product in humans. As a result, it is not considered a therapeutic target, receptor, enzyme, or otherwise druggable protein[1][6]. Its biological roles, if any, are not established, and there are no documented drug interactions, biomarker roles, or disease associations for this locus. Note: There is redundancy and confusion in naming due to this being a pseudogene, and in the literature it is not recognized as a protein-coding gene for a functional receptor, transporter, enzyme, or similar molecular target. Any reference to it as "putative protein" reflects uncertainty regarding its actual protein-coding capacity[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A5 (FAM90A5).